Recent Finacing
Recent Raise
JDP Therapeutics develops JDP-205 injectable for acute hospital allergic reactions, completed Phase I/II, secured FDA agreement on a pivotal Phase III protocol, and maintains a commercial supply agreement.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor